Healthcare Leads, Event Risk Builds
August 10, 2026
Healthcare owns the strongest three-month trend, while technology’s latest burst is concentrated in a few sharp moves. The tape remains constructive, but this week’s earnings calendar will test how much expectation is already embedded in the leaders.
The sector tape
Healthcare has gained 15.0% over three months and leads the S&P 500 by 4.2 percentage points on the scan’s relative-strength measure. Financials rank second, up 12.1% over three months and 3.5 points ahead of the index. Industrials match the benchmark on relative strength after a 6.7% three-month gain. This is a broader foundation than a technology-only advance.
Technology’s 7.2% weekly rise looks powerful, but its one-month gain is only 1.4% and its relative edge over the index is 1.7 points. Two optical names account for some of the heat: COHR rose 44.2% in a week and LITE gained 24.7%, both ahead of earnings. Those moves show where attention has crowded. They do not yet establish durable sector leadership.
What the scan adds
The radar reviewed 1,357 names. Eleven of the top 25 came from healthcare, confirming the sector result at the company level. The strongest candidates are not one uniform group. Liquidia is tied to Yutrepia’s commercial ramp, Cogent Biosciences carries a December 30 regulatory date for bezuclastinib, and BridgeBio’s coming report will update the Attruby launch. Different business drivers sit beneath the same sector leadership.
Extension is the common risk. Liquidia has advanced 113.4% over three months and sits at its 52-week high before August 12 earnings. Cogent is only 1.1% below its high before its August 11 report. Brinker International has gained 53.9% in three months and is 0.9% below its high ahead of August 12 results. Strong structures can remain strong, but a dense calendar gives the market fresh evidence against elevated expectations.
The screen also finds leadership away from healthcare. KB Financial sits at a 52-week high while financials hold the second-best relative-strength reading. Tapestry is at its high despite consumer cyclicals trailing the S&P 500 by 3.0 points. Aramark has pulled back 3.3% over one month within a 24.5% three-month advance. These names show three distinct conditions: sector confirmation, company strength against a weak group, and consolidation within an established trend.
Thesis, trigger and invalidation
The thesis is that the market still has enough participation to absorb uneven results because healthcare and financials lead over three months while technology supplies shorter-term momentum. Confirmation would come from healthcare retaining its relative advantage after the August 11–13 reporting cluster, with financials continuing to outperform the index.
The view weakens if healthcare’s leaders lose their intermediate support together after earnings and technology’s weekly surge fades without broader participation. A simultaneous breakdown in both groups would leave the advance dependent on fewer sectors. That would be a material change from the current tape.
Market analysis, not personalized investment advice.
Publisher Disclosure. Curve Ahead Market Strategies publishes an impersonal business and financial publication of general and regular circulation. The content is identical for all subscribers and is not tailored to any person’s portfolio, investment objectives, risk tolerance, tax status, liquidity needs, or other circumstances. We do not provide individualized investment advice through email, chat, customer support, social media, or any other channel. Any discussion of a security reflects the publisher’s editorial views only and is not a request, instruction, or recommendation that any reader buy, sell, hold, or use any specific investment strategy.
Conflicts & Compensation. Principals, employees, or affiliates of the publisher may hold positions in securities discussed in this publication. Under the publisher’s personal-trading policy, principals do not trade a covered security from two trading days before through two trading days after the publisher posts coverage of that security, and where a principal holds a position in a security discussed, the publication states so. Neither the publisher nor its principals, employees, or affiliates received compensation from any issuer, underwriter, or dealer in connection with this publication. If any such compensation ever exists, the publication will clearly disclose its source, amount, type, and timing.
Risk. Investing involves risk, including possible loss of principal. Markets change; nothing described here is a prediction or guarantee of any outcome.